Cas:787523-31-3 3-benzyl-5-methylimidazole-4-carboxylic acid manufacturer & supplier

We serve Chemical Name:3-benzyl-5-methylimidazole-4-carboxylic acid CAS:787523-31-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-benzyl-5-methylimidazole-4-carboxylic acid

Chemical Name:3-benzyl-5-methylimidazole-4-carboxylic acid
CAS.NO:787523-31-3
Synonyms:3-benzyl-5-methylimidazole-4-carboxylic acid
Molecular Formula:C12H12N2O2
Molecular Weight:216.23600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.12000
Exact Mass:216.09000
LogP:1.93800

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-benzyl-5-methylimidazole-4-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-benzyl-5-methylimidazole-4-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-benzyl-5-methylimidazole-4-carboxylic acid Use and application,3-benzyl-5-methylimidazole-4-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. 3-benzyl-5-methylimidazole-4-carboxylic acid manufacturer The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. 3-benzyl-5-methylimidazole-4-carboxylic acid supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 3-benzyl-5-methylimidazole-4-carboxylic acid vendor A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. 3-benzyl-5-methylimidazole-4-carboxylic acid factory Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.